HOME › DRUGS › DAPAGLIFLOZIN;METFORMIN
ACTIVE SUBSTANCE / INN

DAPAGLIFLOZIN;METFORMIN

Brand name(s): Xigduo, Ebymect
EMA LISTED
AUTHORISED
Diabetes Mellitus, Type 2
ACTIVE SUBSTANCE
Dapagliflozin;Metformin
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
EbymectAstraZeneca ABAuthorised15/11/2015Diabetes Mellitus, Type 2
XigduoAstraZeneca ABAuthorised16/01/2014Diabetes Mellitus, Type 2

FULL INTELLIGENCE ON DAPAGLIFLOZIN;METFORMIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →